🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the makers of Tylenol, alleging the firms concealed safety concerns that the drug created to pediatric neurological development.

This legal action follows a month after Donald Trump promoted an unverified association between taking acetaminophen - also known as acetaminophen - throughout gestation and autism in young ones.

Paxton is suing J&J, which previously sold the medication, the sole analgesic suggested for women during pregnancy, and the current manufacturer, which now manufacturers it.

In a statement, he stated they "betrayed America by making money from pain and pushing pills ignoring the risks."

The manufacturer states there is lacking scientific proof tying Tylenol to autism.

"These companies lied for decades, deliberately risking numerous people to increase profits," Paxton, a Republican, declared.

Kenvue said in a statement that it was "deeply concerned by the spread of false claims on the reliability of paracetamol and the potential impact that could have on the health of American women and children."

On its website, Kenvue also stated it had "continuously evaluated the pertinent research and there is insufficient valid information that indicates a proven link between using acetaminophen and autism spectrum disorder."

Associations representing physicians and health professionals agree.

ACOG has declared paracetamol - the primary component in Tylenol - is among limited choices for women during pregnancy to manage pain and elevated temperature, which can pose major wellness concerns if not addressed.

"In more than two decades of research on the utilization of paracetamol in gestation, no reliable research has definitively established that the consumption of acetaminophen in any period of pregnancy results in neurological conditions in offspring," the association commented.

The lawsuit mentions current declarations from the Trump administration in claiming the medication is reportedly hazardous.

Recently, Trump raised alarms from public health officials when he advised women during pregnancy to "resist strongly" not to consume acetaminophen when unwell.

Federal regulators then released a statement that doctors should contemplate reducing the consumption of Tylenol, while also stating that "a causal relationship" between the medication and autism spectrum disorder in minors has not been proven.

The Health Department head Robert F Kennedy Jr, who oversees the FDA, had vowed in spring to initiate "comprehensive study program" that would identify the cause of autism in a matter of months.

But specialists warned that finding a single cause of autism - thought by researchers to be the consequence of a intricate combination of genetic and surrounding conditions - would be difficult.

Autism is a type of enduring cognitive variation and disability that impacts how individuals encounter and engage with the world, and is recognized using physician assessments.

In his legal document, Paxton - aligned with the former president who is seeking US Senate - asserts the manufacturer and J&J "intentionally overlooked and sought to suppress the research" around paracetamol and autism.

The lawsuit attempts to require the firms "destroy any marketing or advertising" that asserts acetaminophen is reliable for pregnant women.

The Texas lawsuit echoes the concerns of a assembly of parents of children with autism spectrum disorder and ADHD who filed suit against the makers of Tylenol in two years ago.

The court threw out the lawsuit, saying research from the family's specialists was not conclusive.